These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6891626)

  • 1. Human tissue distribution of platinum after cis-diamminedichloroplatinum.
    Stewart DJ; Benjamin RS; Luna M; Feun L; Caprioli R; Seifert W; Loo TL
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):51-4. PubMed ID: 6891626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An autopsy case of rectal cancer receiving cisplatin at total dose of 3.250 mg and platinum concentrations in autopsy tissue samples].
    Ishigaki H; Satoh S; Saitoh S; Yoshida Y; Ebina T; Satoh T; Nara K; Asano M; Oh-ishi S; Satoh F
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3805-8. PubMed ID: 2596863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum tissue concentrations following intra-arterial and intravenous cis-diamminedichloroplatinum II in New Zealand white rabbits.
    Carlson JA; Litterst CL; Greenberg RA; Day TG; Masterson BJ
    Am J Obstet Gynecol; 1984 Feb; 148(3):313-7. PubMed ID: 6538067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum concentrations in human autopsy tumor samples.
    Stewart DJ; Mikhael NZ; Nair RC; Kacew S; Montpetit V; Nanji A; Maroun JA; Howard K
    Am J Clin Oncol; 1988 Apr; 11(2):152-8. PubMed ID: 3358362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platinum concentrations in human tissue after administration of cisplatin].
    Tochigi T; Ono K; Yoshikawa K; Hoshi S; Orikasa S; Imai Y
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):269-75. PubMed ID: 3341789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases.
    Civalleri D; Esposito M; Fulco RA; Vannozzi M; Balletto N; De Cian F; Percivale PL; Merlo F
    Cancer; 1991 Sep; 68(5):988-94. PubMed ID: 1913493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
    Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
    Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cis-diamminedichloroplatinum (II) to chromatin. Specificity of the drug distribution.
    Foka M; Paoletti J
    Biochem Pharmacol; 1986 Oct; 35(19):3283-91. PubMed ID: 3768022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications.
    Vermorken JB; van der Vijgh WJ; Klein I; Gall HE; Pinedo HM
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1069-74. PubMed ID: 6891650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II).
    Lautersztain J; Perez-Soler R; Khokhar AR; Newman RA; Lopez-Berestein G
    Cancer Chemother Pharmacol; 1986; 18(2):93-7. PubMed ID: 3791565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L
    Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage of pregnancy-dependent transplacental passage of 195mPt after cis-platinum treatment.
    Köpf-Maier P
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):533-6. PubMed ID: 6683188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.
    Stewart DJ; Dulberg C; Molepo JM; Mikhael NZ; Montpetit VA; Redmond MD; Goel R
    Cancer Chemother Pharmacol; 1994; 34(1):14-22. PubMed ID: 8174197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. I: On the effects of intravesical instillation of cis-diamminedichloroplatinum in normal beagle dogs].
    Hirao Y; Iwai A; Yoshie T; Moriya A; Matsuki H; Yoshida K; Sanma S; Kubota K; Ohara S; Babaya K
    Hinyokika Kiyo; 1985 Jan; 31(1):31-8. PubMed ID: 4039525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.
    Stewart DJ; Mikhael NZ; Nanji AA; Nair RC; Kacew S; Howard K; Hirte W; Maroun JA
    J Clin Oncol; 1985 Sep; 3(9):1251-6. PubMed ID: 4040958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. II. On the effects of intravesical instillation of cis-diamminedichloroplatinum in bladder cancer patients].
    Hirao Y; Iwai A; Moriya A; Matsuki H; Yoshida Y; Komada S; Sasaki K; Kubota K; Sanma S; Babaya K
    Hinyokika Kiyo; 1985 Sep; 31(9):1565-73. PubMed ID: 4083214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
    Masuda H; Tanaka T; Matsuda H; Kusaba I
    Cancer Res; 1990 Mar; 50(6):1863-6. PubMed ID: 2306738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.
    Steerenberg PA; Storm G; de Groot G; Claessen A; Bergers JJ; Franken MA; van Hoesel QG; Wubs KL; de Jong WH
    Cancer Chemother Pharmacol; 1988; 21(4):299-307. PubMed ID: 3370737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney.
    Suzuki CA; Cherian MG
    Toxicology; 1990 Nov; 64(2):113-27. PubMed ID: 1977210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
    Fichtinger-Schepman AM; Vendrik CP; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; Claessen AM; van der Velde-Visser SD; de Groot G; Wubs KL; Steerenberg PA
    Cancer Res; 1989 Jun; 49(11):2862-7. PubMed ID: 2720647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.